These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22966736)

  • 1. Opportunity for healthy ageing: lessening the burden of adult pneumococcal disease in Central and Eastern Europe, and Israel.
    Ludwig E; Unal S; Bogdan M; Chlibek R; Ivanov Y; Kozlov R; van der Linden M; Lode H; Mészner Z; Prymula R; Rahav G; Skoczynska A; Solovic I; Uzaslan E
    Cent Eur J Public Health; 2012 Jun; 20(2):121-5. PubMed ID: 22966736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal disease in the Arabian Gulf: recognizing the challenge and moving toward a solution.
    Feldman C; Abdulkarim E; Alattar F; Al Lawati F; Al Khatib H; Al Maslamani M; Al Obaidani I; Al Salah M; Farghaly M; Husain EH; Mokadas E
    J Infect Public Health; 2013 Dec; 6(6):401-9. PubMed ID: 23999349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Ambrose A; Hatchette TF; Lang ALS; Gillis HD; Martin I; Demczuk W; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy AE; McGeer A; Semret M; Trottier S; Valiquette L; Webster D; McNeil SA
    Vaccine; 2019 Aug; 37(36):5466-5473. PubMed ID: 31345638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
    Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
    Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
    Sings HL
    Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
    Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
    Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteremic Pneumonia before and after Withdrawal of 13-Valent Pneumococcal Conjugate Vaccine from a Public Vaccination Program in Spain: A Case-Control Study.
    Tagarro A; Benito A; Sánchez A; Aznar E; Otheo E; Sanz-Rosa D;
    J Pediatr; 2016 Apr; 171():111-5.e1-3. PubMed ID: 26787377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7.
    Regev-Yochay G; Rahav G; Strahilevitz J; Bishara J; Katzir M; Chowers M; Finkelstein R; Chazan B; Zimhony O; Dagan R;
    Vaccine; 2013 May; 31(19):2387-94. PubMed ID: 23518404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the burden of pneumococcal disease in adults.
    Blasi F; Mantero M; Santus P; Tarsia P
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():7-14. PubMed ID: 22882668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult invasive pneumococcal disease in the Republic of Korea: Risk medical conditions and mortality stratified by age group.
    Kim JH; Baik SH; Chun BC; Song JY; Bae IG; Kim HY; Kim DM; Choi YH; Choi WS; Jo YM; Kwon HH; Jeong HW; Kim YS; Kim JY; Lee J; Kee SY; Hur J; Chung JW; Hwang KE; Kim MJ
    Int J Infect Dis; 2018 Sep; 74():136-144. PubMed ID: 30055332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of pneumococcal diseases in Central and Eastern Europe.
    Ceyhan M; Dagan R; Sayiner A; Chernyshova L; Dinleyici EÇ; Hryniewicz W; Kulcsár A; Mad'arová L; Pazdiora P; Sidorenko S; Streinu-Cercel A; Tambić-Andrašević A; Yeraliyeva L
    Hum Vaccin Immunother; 2016 Aug; 12(8):2124-2134. PubMed ID: 27096714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
    Choi YH; Andrews N; Miller E
    PLoS Med; 2019 Jul; 16(7):e1002845. PubMed ID: 31269018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population.
    Castañeda-Orjuela C; Alvis-Guzmán N; Paternina AJ; De la Hoz-Restrepo F
    Vaccine; 2011 Oct; 29(44):7644-50. PubMed ID: 21854825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.
    Chowers M; Regev-Yochay G; Mor O; Cohen-Poradosu R; Riesenberg K; Zimhony O; Chemtob D; Stein M; Dagan R; Levy I
    Hum Vaccin Immunother; 2017 Jan; 13(1):216-219. PubMed ID: 27648488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study.
    Regev-Yochay G; Paran Y; Bishara J; Oren I; Chowers M; Tziba Y; Istomin V; Weinberger M; Miron D; Temper V; Rahav G; Dagan R;
    Vaccine; 2015 Feb; 33(9):1135-42. PubMed ID: 25613717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pneumococcal vaccine recommendations in chronic respiratory diseases].
    Casas Maldonado F; Alfageme Michavila I; Barchilón Cohen VS; Peis Redondo JI; Vargas Ortega DA
    Semergen; 2014 Sep; 40(6):313-25. PubMed ID: 25107494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel.
    Regev-Yochay G; Katzir M; Strahilevitz J; Rahav G; Finn T; Miron D; Maor Y; Chazan B; Schindler Y; Dagan R;
    Vaccine; 2017 Apr; 35(18):2449-2456. PubMed ID: 28342668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination.
    Orsi A; Ansaldi F; Trucchi C; Rosselli R; Icardi G
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.